Dallah Healthcare Company SJSC
SAU:4004

Watchlist Manager
Dallah Healthcare Company SJSC Logo
Dallah Healthcare Company SJSC
SAU:4004
Watchlist
Price: 162.2 SAR 0.12% Market Closed
Market Cap: 15.8B SAR
Have any thoughts about
Dallah Healthcare Company SJSC?
Write Note
Section:
 

Relative Value

The Relative Value of one Dallah Healthcare Company SJSC stock under the Base Case scenario is 199.18 SAR. Compared to the current market price of 162.2 SAR, Dallah Healthcare Company SJSC is Undervalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
199.18 SAR
Undervaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.9
P/S
P/S
Price to Sales
4.9
vs History
22
vs Industry
31
Median 3Y
4.9
Median 5Y
4
Industry
2.3
Forward
4.7
More Details
33.5
P/E
P/E
Price to Earnings
33.5
vs History
44
vs Industry
17
Median 3Y
35.4
Median 5Y
33.5
Industry
23.1
Forward
32.4
More Details
20.3
P/OCF
P/OCF
Price to OCF
20.3
vs History
63
vs Industry
18
Median 3Y
26.6
Median 5Y
22.6
Industry
14.2
More Details
38.9
P/FCFE
P/FCFE
Price to FCFE
38.9
vs History
30
vs Industry
12
Median 3Y
38.9
Median 5Y
22.1
Industry
20.1
More Details
4.6
P/B
P/B
Price to Book Value
4.6
vs History
39
vs Industry
18
Median 3Y
4.8
Median 5Y
4.5
Industry
2.2
More Details
5.5
EV/S
EV/S
Enterprise Value to Sales
5.5
vs History
23
vs Industry
25
Median 3Y
5.5
Median 5Y
4.7
Industry
2.4
Forward
5.3
More Details
14.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
14.5
vs History
30
vs Industry
16
Median 3Y
14.5
Median 5Y
13.1
Industry
5
More Details
24.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
24.3
vs History
26
vs Industry
15
Median 3Y
24.3
Median 5Y
21.8
Industry
12.7
Forward
23.2
More Details
30
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30
vs History
47
vs Industry
16
Median 3Y
30
Median 5Y
30
Industry
17.1
Forward
29.1
More Details
22.6
EV/OCF
EV/OCF
Enterprise Value to OCF
22.6
vs History
73
vs Industry
17
Median 3Y
29.3
Median 5Y
26.3
Industry
14
More Details
49.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
49.2
vs History
60
vs Industry
11
Median 3Y
51.5
Median 5Y
53.5
Industry
18
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
31
vs Industry
27
Median 3Y
2.9
Median 5Y
2.7
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Dallah Healthcare Company SJSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Dallah Healthcare Company SJSC
SAU:4004
15.8B SAR 4.9 33.5 24.3 30
US
HCA Healthcare Inc
NYSE:HCA
78.3B USD 1.1 13.3 8.3 10.9
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.8B CNY 6.3 35.8 27.1 27.1
MY
IHH Healthcare Bhd
KLSE:IHH
63.4B MYR 2.7 23.9 12.9 18.7
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.8 106.6 74.1 88.3
US
Tenet Healthcare Corp
NYSE:THC
12.4B USD 0.6 3.9 5.2 6.6
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.7 42 57.5
US
Universal Health Services Inc
NYSE:UHS
12B USD 0.8 11.7 7.8 10.7

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.